Home » Newsletters » BioWorld MedTech

BioWorld MedTech

Feb. 5, 2016

View Archived Issues

Looking to Replace traditional syringes :Mexican millennials developing futuristic med-tech products

Smart lens technology used in variety of disease states by firms: Smart contact lens could chronicle glaucoma progression in patients

Financings: Airo gets $2.5 million to advance technology

Daily M&A.: Endologix strengthens position in EVAR market with Trivascular buy

Patents

Products

MDD's Diagnostics Extra

Inside the Beltway: NHLBI cites need for next-gen VADs in research priorities

Today's news in brief
BioWorld
BioWorld briefs for Nov. 27, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for November 27, 2024.
In muscular dystrophies, gene therapies race the clock
BioWorld
Since the isolation of the gene that causes Duchenne muscular dystrophy (DMD), scientists have progressed in understanding the mechanisms that lead to muscular...
Bridgebio, with FDA approval, faces Pfizer in ATTR
BioWorld
With the U.S. FDA approval of Attruby (acoramidis) for transthyretin amyloidosis with cardiomyopathy (ATTR-CM), Bridgebio Pharma Inc. is taking on an industry...
‘Evo’ AI can design complete genomes
BioWorld Science
The development of new machine learning tools like Alphafold and Rfdiffusion has allowed scientists to predict the structure of proteins and design them for drug...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.